<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[파미니티 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=48814></link><description><![CDATA[파미니티 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Fri, 24 Apr 2026 12:44:16 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2025/08/12_2056848267_20250825165208_8893259627.png]]></url></image><language>ko-KR</language><item><title><![CDATA[Famenity&#039;s Brain Factor-7® Gains Global Momentum as Clinically Validated Ingredient for Cognitive Health]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1024678</link><description><![CDATA[SEOUL--(Korea Newswire)--Famenity Co., Ltd. , a South Korean research and development company specializing in functional ingredients for health supplements, said that its Brain Factor-7® (BF-7®) is drawing attention among global brands seeking clinical-grade cognitive-support ingredients.  BF-7®, a silk-peptide complex, is backed by over 12 independent human studies acr...]]></description><pubDate>Fri, 05 Dec 2025 11:00:00 +0900</pubDate></item></channel></rss>